A Single-Center, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Alpha Thalassemia Major

Disease Name: 
Alpha Thalassemia Major
Date: 
July 18, 2024